ID: ALA4464758

Max Phase: Preclinical

Molecular Formula: C32H38F3N7O9S

Molecular Weight: 639.74

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cccc(OC)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCN(S(=O)(=O)c2cccc(NC(=O)/C=C/CN(C)C)c2)CC1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C30H37N7O7S.C2HF3O2/c1-36(2)15-7-12-26(38)32-21-8-5-9-22(18-21)45(41,42)37-16-13-20(14-17-37)33-30(40)28-23(19-31-35-28)34-29(39)27-24(43-3)10-6-11-25(27)44-4;3-2(4,5)1(6)7/h5-12,18-20H,13-17H2,1-4H3,(H,31,35)(H,32,38)(H,33,40)(H,34,39);(H,6,7)/b12-7+;

Standard InChI Key:  HFDIDYBEUWMXSL-RRAJOLSVSA-N

Associated Targets(Human)

CDK14 Tchem Cyclin-dependent kinase 14/Cyclin-Y (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK14 Tchem Serine/threonine-protein kinase PFTAIRE-1 (331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 639.74Molecular Weight (Monoisotopic): 639.2475AlogP: 2.32#Rotatable Bonds: 12
Polar Surface Area: 175.06Molecular Species: BASEHBA: 9HBD: 4
#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.74CX Basic pKa: 8.80CX LogP: 1.74CX LogD: 0.42
Aromatic Rings: 3Heavy Atoms: 45QED Weighted: 0.22Np Likeness Score: -1.52

References

1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS..  (2019)  Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.,  29  (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024]

Source